Navigation Links
Nile Therapeutics, Inc. Reports 2008 Third Quarter Financial Results
Date:11/13/2008

637,049) (10,401,001) (6,779,822)

Other income (expense)

Interest income 58,451 58,975 290,734 82,937

Interest

expense - (970,330) (137) (1,089,344)

Other expense (3,679) - (46,523) -

Total other

Income

(expense) 54,772 (911,355) 244,074 (1,006,407)

Net loss $(3,320,889) $(5,548,404) $(10,156,927) $(7,786,229)

Basic and

diluted loss

per share $ (0.14) $ (0.35) $ (0.42) $ (0.54)

Weighted-average

common shares

outstanding 24,149,405 15,977,936 24,118,645 14,532,772

Summary Balance Sheet Data

September December

30, 2008 31, 2007

(unaudited)

Cash & cash

Equivalents $ 7,363,926 $16,233,464

Total assets $ 8,408,902 $17,089,328

Total

stockholder

equity $ 7,490,754 $15,199,932


'/>"/>
SOURCE Nile Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine news :

1. Cell Therapeutics, Inc. (CTI) Rodman & Renshaw Healthcare Conference Presentation to be Webcast
2. Cell Therapeutics, Inc. (CTI) Oppenheimer & Co. Healthcare Conference Presentation to be Webcast
3. Cornerstone Therapeutics, Inc. Taps Josh Franklin to Head Marketing Team
4. Cell Therapeutics, Inc. Announces Single Institutional Investor to Purchase Up to $18 Million of Senior Convertible Notes
5. Cell Therapeutics, Inc. Announces $12 Million Equity Line of Credit
6. Stiefel Laboratories, Inc. Announces Expiration of Hart-Scott-Rodino Waiting Period Relating to its Proposal to Acquire Barrier Therapeutics, Inc.
7. Zevalin Revenues Lead Cell Therapeutics, Inc.s First Quarter 2008 Financial Results
8. Juvaris BioTherapeutics, Inc. Announces the Appointment of Grant E. Pickering as Chief Executive Officer
9. Cell Therapeutics, Inc. (CTI) Reports Recent Accomplishments and 2007 Fourth Quarter and Year End Financial Results
10. Oracle Healthcare Acquisition Corp. and Precision Therapeutics, Inc. Mutually Terminate Merger Agreement; Oracle Healthcare Acquisition Corp. Cancels Special Meeting
11. Cell Therapeutics, Inc. Announces Issuance of $51.7 Million of New 2012 Convertible Senior Notes
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:Misys Announces Preliminary Results for the Year Ended 31 May 2008 2Health News:Misys Announces Preliminary Results for the Year Ended 31 May 2008 3Health News:Misys Announces Preliminary Results for the Year Ended 31 May 2008 4Health News:MediVoice(R) Partners With VisionTree(R) to Integrate Its Voice-Activated e-Prescribing Solution Into VisionTree's VTOC(TM) Web-Based Patient Management System 2Health News:MediVoice(R) Partners With VisionTree(R) to Integrate Its Voice-Activated e-Prescribing Solution Into VisionTree's VTOC(TM) Web-Based Patient Management System 3Health News:Cardiome Announces Preferred Share Financing 2Health News:Cardiome Announces Preferred Share Financing 3Health News:Study suggests human visual system could make powerful computer 2Health News:Study suggests human visual system could make powerful computer 3Health News:$15 Million Donation From The Karabots Foundation Enables The Children's Hospital of Philadelphia to Open a New Pediatric Care Facility in Norristown, Pennsylvania 2Health News:$15 Million Donation From The Karabots Foundation Enables The Children's Hospital of Philadelphia to Open a New Pediatric Care Facility in Norristown, Pennsylvania 3Health News:Rock The Cradle's Bad Boy Landon Brown Owes His Irresistible New Smile to Dr. Michael Kosdon 2
Breaking Medicine Technology:Cambridge Scientists Archive 500,000th Crystal Structure 2New National Pharmaceutical Council Report Provides Guidance on Evaluating Comparative Effectiveness Studies 2Arrayit Diagnostics Announces Sponsored Research Agreement With Wayne State University and Arrayit Corporation 2Arrayit Diagnostics Announces Sponsored Research Agreement With Wayne State University and Arrayit Corporation 3Arrayit Diagnostics Announces Sponsored Research Agreement With Wayne State University and Arrayit Corporation 4Quest Diagnostics HemoCue AB Subsidiary to Add Avie 28TM 29 Hemoglobin A1c to Diabetes Point of Care Test Suite 47624 1Quest Diagnostics HemoCue AB Subsidiary to Add Avie 28TM 29 Hemoglobin A1c to Diabetes Point of Care Test Suite 47624 2Quest Diagnostics HemoCue AB Subsidiary to Add Avie 28TM 29 Hemoglobin A1c to Diabetes Point of Care Test Suite 47624 3Quest Diagnostics HemoCue AB Subsidiary to Add Avie 28TM 29 Hemoglobin A1c to Diabetes Point of Care Test Suite 47624 4Versus Technology Inc Announces Sale of Real Time Location Information System to the Chalmers P Wylie Veterans Clinic 47620 1Versus Technology Inc Announces Sale of Real Time Location Information System to the Chalmers P Wylie Veterans Clinic 47620 2Versus Technology Inc Announces Sale of Real Time Location Information System to the Chalmers P Wylie Veterans Clinic 47620 3Cynosure Announces Presentations at Upcoming Investor Conferences 12420 1Cynosure Announces Presentations at Upcoming Investor Conferences 12420 2